Evidence map›Paper›PMID 31127560›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

Metabolomics Analyses from Tissues in Parkinson's Disease.

Fatema Bhinderwala, Shulei Lei, Jade Woods, Jordan Rose, Darrell D Marshall, Eli Riekeberg, Aline De Lima Leite, Martha Morton, Eric D Dodds, Rodrigo Franco and 1 more

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Best Practices in NMR Metabolomics: Current State.Trends in analytical chemistry : TRAC · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Chemical shift variations in common metabolites.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fatema BhinderwalaDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Shulei LeiDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Jade WoodsDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Jordan RoseSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA.
Darrell D MarshallDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Eli RiekebergDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Aline De Lima LeiteDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Martha MortonDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Eric D DoddsDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Rodrigo FrancoSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA. rodrigo.franco@unl.edu.
Robert PowersDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA. rpowers3@unl.edu.

Funding

Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI RAZAVI RIZI, MOHAMMAD · 2016 to 2025
$20.8M
Redox Biology CenterP30GM103335 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2012 to 2016
$4.3M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015468 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI PAUL, PREM S · 2000 to 2000
$2.0M
NCRR NIH HHS C06 RR015468NIGMS NIH HHS P20 GM113126NIGMS NIH HHS P30 GM103335
6 · The paper itself

Abstract

Metabolomics has been successfully applied to study neurological and neurodegenerative disorders including Parkinson's disease for (1) the identification of potential biomarkers of onset and disease progression; (2) the identification of novel mechanisms of disease progression; and (3) the assessment of treatment prognosis and outcome. Reproducible and efficient extraction of metabolites is imperative to the success of any metabolomics investigation. Unlike other omics techniques, the composition of the metabolome can be negatively impacted by the preparation, processing, and handling of these samples. The proper choice of data collection, preprocessing, and processing protocols is similarly important to the design of an effective metabolomics experiment. Likewise, the correct application of univariate and multivariate statistical methods is essential for providing biologically relevant insights. In this chapter, we have outlined a detailed metabolomics workflow that addresses all of these issues. A step-by-step protocol from the preparation of neuronal cells and metabolomic tissue samples to their metabolic analyses using nuclear magnetic resonance, mass spectrometry, and chemometrics is presented.

Indexed as

AnimalsAstrocytesBiomarkersBrainCarbon IsotopesCell Line, TumorDisease Models, AnimalDisease ProgressionHumansMetabolomicsMiceNeuronsNitrogen IsotopesParkinson DiseasePrimary Cell CultureRatsBiomarkersCarbon-13Carbon IsotopesNitrogen-15Nitrogen IsotopesChemometricsMass spectrometryMetabolomicsNeurodegenerationNMRParkinson’s disease

Identifiers

PMID31127560
PMCPMC6625357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.